Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1190878 | 0.79 | CYP11B1 (0.58) | CYP11B1CYP11B2MAPT | |
| SCHEMBL10453099 | 0.71 | — | — | |
| SCHEMBL1190056 | 0.68 | ALDH1A1 (0.46) | CYP11B1CYP11B2GAAMAPT | |
| SCHEMBL2119149 | 0.67 | CHRNB2 (0.33) | GAAMAPTIDO1L3MBTL1 | |
| SCHEMBL18537501 | 0.67 | CCNC (0.33) | GAAMAPTIDO1L3MBTL1 | |
| SCHEMBL8502145 | 0.65 | CYP11B1 (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL1191106 | 0.64 | CYP11B1 (0.55) | CYP11B1CYP11B2GAAMAPT | |
| SCHEMBL12210343 | 0.64 | GAA (0.34) | GAAMAPTIDO1L3MBTL1 | |
| SCHEMBL24869481 | 0.64 | CHRNB2 (0.38) | CYP11B1CYP11B2GAAMAPTIDO1 | |
| Hydrochloric Acid SCHEMBL21824331 | 0.63 | CYP11B1 (0.54) | CYP11B1CYP11B2GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312474-A1 | PHENOL DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230312474-A1 | PHENOL DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-10-05 | — | — | US | disclosed |
| EP-4206184-A1 | PHENOL DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-07-05 | — | — | EP | disclosed |
| WO-2021039968-A1 | 2-AMINOQUINAZOLINONE DERIVATIVE | 大日本住友製薬株式会社 | 2021-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312474-A1 | PHENOL DERIVATIVE | TYR, NCOR1, BET1 | CYP11B1 155/4885CYP11B2 92/4885GAA 2677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.